To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
Podcast 72: A conversation about two new drugs for multiple sclerosis.
Joe Elia • January 29th, 2010
Categories: Audio, cladribine, fingolimod, multiple sclerosis, Uncategorized
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.
- New York Times series on radiation safety
- Lancet study on glycated hemoglobin levels
- FDA approval of diabetes drug
- JNCI study on ovarian cancer symptoms